Optimising the Duration of Therapy for Newly Diagnosed Transplant Ineligible Patients - Analysis of Long Term Follow up Data from the UK MRA Myeloma XI Trial

Pawlyn, C., Davies, F.E., Cook, G. orcid.org/0000-0001-7196-7364 et al. (16 more authors) (2024) Optimising the Duration of Therapy for Newly Diagnosed Transplant Ineligible Patients - Analysis of Long Term Follow up Data from the UK MRA Myeloma XI Trial. In: Blood. The 66th ASH Annual Meeting, 07-10 Dec 2024, San Diego, USA. American Society of Hematology , pp. 1987-1988.

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Pawlyn, C. Davies, F.E. Cook, G. https://orcid.org/0000-0001-7196-7364 McIntyre, H. Richards, J. Jackson, S. Hodson, E. Olivier, C. https://orcid.org/0009-0003-3432-9963 Hockaday, A. Jones, J.R. Kaiser, M.F. Jenner, M.W. Gregory, W.M. de Tute, R.M. Owen, R.G. Drayson, M. Cairns, D.A. https://orcid.org/0000-0002-2338-0179 Morgan, G. Jackson, G.
Dates:	Published: 5 November 2024
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	08 Jul 2025 13:27
Last Modified:	08 Jul 2025 13:27
Status:	Published
Publisher:	American Society of Hematology
Identification Number:	10.1182/blood-2024-205788
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:228651

CORE (COnnecting REpositories)

Optimising the Duration of Therapy for Newly Diagnosed Transplant Ineligible Patients - Analysis of Long Term Follow up Data from the UK MRA Myeloma XI Trial

Metadata

Download not available

Export

Statistics